Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Grafix for Treatment of Diabetic Foot Ulcers

Discussion in 'Diabetic Foot & Wound Management' started by NewsBot, Aug 13, 2013.

  1. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1

    Members do not see these Ads. Sign Up.
    Press Release:
    Grafix® Demonstrates Overwhelming Efficacy in Landmark Stem Cell Study
    for the Treatment of Diabetic Foot Ulcers


     
  2. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Re: Grafix for Treat Diabetic Foot Ulcers

    Press Release:
    Grafix(R) Diabetic Foot Ulcer Clinical Trial Accepted for Presentation at the 2013 Symposium on Advanced Wound Care
     
  3. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Re: Grafix for Treat Diabetic Foot Ulcers

    FDA Slaps Osiris For Misleading Medical Claims About Stem-Cell Bandage
    Full story
     
  4. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
  5. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    Osiris to Present Grafix(R) Clinical and Scientific Data at 10th Annual Desert Foot High Risk Diabetic Foot Conference
    Grafix featured in ten clinical and scientific presentation and poster sessions with new data on long-term wound closure rates from its multi-center, randomized clinical trial including reduction in infection rates and hospitalizations
     
  6. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    Journal Publishes Grafix® Clinical Study for Chronic Wounds
    Grafix demonstrates an overall closure rate of 76% among chronic, recalcitrant wounds further supporting evidence from its recent Diabetic Foot Ulcer trial
     
  7. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    A retrospective analysis of a human cellular repair matrix for the treatment of chronic wounds.
    Regulski M1, Jacobstein DA2, Petranto RD3, Migliori VJ3, Nair G3, Pfeiffer D3.
    Ostomy Wound Manage. 2013 Dec;59(12):38-43.
     
  8. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press release:
    Grafix® Pharmacoeconomic and Scientific Characterization Studies Featured at the 2014 Spring Symposium for Advanced Wound Care
     
  9. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    Grafix(R) Manuscript from Osiris' Multi-center, Randomized, Controlled Clinical Trial Accepted in Peer-Reviewed Journal
     
  10. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    Grafix® Manuscript from Osiris’ Multi-center, Randomized, Controlled Clinical Trial Available Electronically in Peer-Reviewed Journal
     
  11. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    The efficacy and safety of Grafix® for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial.
    Lavery LA, Fulmer J, Shebetka KA, Regulski M, Vayser D, Fried D, Kashefsky H, Owings TM, Nadarajah J; The Grafix Diabetic Foot Ulcer Study Group.
    Int Wound J. 2014 Jul 21. doi: 10.1111/iwj.12329.
     
  12. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Press Release:
    Grafix® Randomized Controlled Clinical Trial Recognized As High Quality DFU Trial In Recent Wounds Supplement
     
  13. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
  14. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Comparative Effectiveness of a Bioengineered Living Cellular Construct vs. a Dehydrated Human Amniotic Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real World Setting
    Robert S. Kirsner et al
    Wound Repair and Regeneration; Accepted Article
     
  15. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Grafix®, a Cryopreserved Placental Membrane, for the Treatment of Chronic/Stalled Wounds
    Gibbons Gary W.
    Advances in Wound Care. July 22, 2015
     
  16. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
  17. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    The clinical effectiveness
    of cryopreserved human amniotic
    membrane in diabetic foot syndrome

    Ustymenko A et al
    Cell and Organ Transplantology. 2021; 9(2):80-87
     
Loading...

Share This Page